Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An announcement from Kontafarma China Holdings Ltd ( (HK:1312) ) is now available.
Kontafarma China Holdings plans to adopt a fourth amended and restated memorandum and articles of association to align its constitutional documents with updated Hong Kong legal and regulatory requirements on electronic dissemination of corporate communications. The changes would also allow the company to hold and dispose of repurchased shares as treasury shares and include various housekeeping updates, subject to shareholder approval by special resolution at the annual general meeting scheduled for 5 June 2026.
The company will close its register of members from 1 to 5 June 2026 to determine shareholder eligibility to attend and vote at the meeting, with share transfer documents required to be lodged by 29 May 2026. These steps formalize the governance framework around electronic communications and treasury share management and clarify key dates for investors seeking to participate in the approval process.
More about Kontafarma China Holdings Ltd
Kontafarma China Holdings Ltd is a Cayman Islands-incorporated company listed in Hong Kong. It operates under a board structure comprising executive, non-executive and independent non-executive directors, reflecting typical Hong Kong-listed corporate governance standards and regulatory oversight.
Average Trading Volume: 1,458,687
Technical Sentiment Signal: Sell
Current Market Cap: HK$167.4M
Find detailed analytics on 1312 stock on TipRanks’ Stock Analysis page.